Cynata Therapeutics Limited (ASX:CYP)

Cynata Therapeutics Revenue

In the fiscal year ending June 30, 2026, Cynata Therapeutics had annual revenue of 1.71M AUD, down -9.20%. That makes Cynata Therapeutics the 43,289th largest company in the world by revenue and 936th in Australia.

• Revenue: 1.71M
• Revenue Growth: -9.20%
• P/S Ratio: 1.99
• Revenue / Employee: 855.81K
• Employees: 2
• Market Cap: 3.41M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.71M	-173.52K	-9.20%
Jun 30, 2025	1.89M	-430.50K	-18.59%
Jun 30, 2024	2.32M	661.33K	39.98%
Jun 30, 2023	1.65M	-6.12M	-78.71%
Jun 30, 2022	7.77M	6.22M	402.60%

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 5, 2026

Data Sources Report a data error